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INTRODUCTION:  Complex  hernias  continue  to present  a challenge.  Surgical  techniques  for  repair  are  care-
fully  considered  to reduce  risk  for complications.  Laparoscopic  repairs  improve  postoperative  infection
rates,  and  placement  of biologic  mesh  decreases  mesh  infection  rates.  However,  laparoscopic  repairs
using  biologic  mesh  is generally  challenging  due  to difﬁculty  with  maneuverability.
PRESENTATION  OF  CASE:  We  present  a case  of  a complex  ventral  hernia  that  was  laparoscopically  repaired
using  a new  FDA  cleared  laparoscopic  biologic  graft.  The  patient  had  multiple  comorbidities,  including
obesity,  hepatitis  C,  endocarditis  secondary  to IV drug  use,  tobacco  smoking,  bilateral  inguinal  hernia,
and  recurrent  umbilical  hernia.  The  recurrent  hernia  was larger,  irreducible,  and  discolored  compared  to
original  defect.  The  patient  underwent  laparoscopic  repair with  primary  closure  and reinforcement  with
StratticeTM Tissue  Matrix  Laparoscopic  (LifeCell  Corporation,  Branchburg,  NJ).  At  nine  months  postopera-
tive,  the  patient  had  no  evidence  of recurrence,  infection,  or chronic  pain,  demonstrating  early  success
from  the surgical  management.
DISCUSSION:  Presence  of multiple  comorbidities  and  incarcerated  recurrent  hernia  increase  risk for  com-
plications  during  and/or  after  hernia  repair.  Considering  these  factors,  laparoscopic  repair  with  Strattice
Laparoscopic  and  defect  closure  was  a reasonable  technique  for repair.
CONCLUSION:  Laparoscopic  suture  repair  reinforced  with  biologic  dermal  tissue  matrix  was  successfully
performed  during  a complex  hernia  repair.
©  2014  The  Author.  Published  by  Elsevier  Ltd.  on behalf  of Surgical  Associates  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Although over 350,000 ventral or incisional hernia repairs are
erformed annually in the United States, complex hernias con-
inue to present a challenge due increased risk for complications.
election of repair techniques must be carefully considered in com-
licated settings. Increasing numbers of surgeons perform mesh
epairs as the standard approach; however, different types of mesh
ave their own advantages and disadvantages. Synthetic prosthe-
es have been shown to be durable with lower recurrence rates but
re associated with high incidence of infection.1 Conversely, bio-
ogic meshes are designed to promote vascularization and tissue
ntegration and have the ability to resist infection.2 Thus, place-
ent of biologic grafts are generally recommended for patients at
ncreased risk for wound complications.1,3
The outcomes of hernia repairs may  also be affected by the
urgical approach. Laparoscopic repairs are associated with fewer
ound-related complications and recurrences compared to an
pen repair, which may  be beneﬁcial for complicated hernias.4,5
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Despite the beneﬁts of the two distinct approaches, there is a
paucity of data on the use of biologic mesh in laparoscopic hernia
repairs. Anecdotally, placing a biologic mesh laparoscopically can
be challenging. Difﬁculty with ﬁxation, deployment, and handling
may  be attributed to the thickness and ﬁrm nature of biologic mesh.
We present a laparoscopic hernia repair using biologic mesh for an
incarcerated, recurrent umbilical hernia in a patient at increased
risk for complications.
2. Presentation of case
The patient is a 33-year old male with a history of obesity, hep-
atitis C, endocarditis secondary to IV drug use, and tobacco smoking
(15 pack years). In addition, he had a history of laparoscopic
bilateral inguinal hernia repair through a total extra-peritoneal
approach with a concomitant laparoscopic umbilical hernia repair
for a 3 cm defect. The umbilical hernia repair was  repaired with a
prosthetic composite mesh, placed in the underlay position with
no primary closure of the defect. His initial post-operative course
was unremarkable except for an umbilical seroma which resolved
spontaneously by six weeks.
The patient presented 10 months later complaining of new-
onset pain and a bulge at the umbilicus larger than his initial defect
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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sig. 1. This ﬁgure illustrates the incarcerated prosthetic mesh and omentum
evealed upon lysis of adhesions.
nd that was not easily reducible. On examination, he was  afebrile,
ad a body mass index of 38 kg/m2, and had an incarcerated, tender,
.5 cm umbilical hernia with associated skin changes characterized
y underlying venous congestion and ecchymoses of the umbilical
kin. The patent was consented for a semi-urgent laparoscopic, pos-
ible open umbilical hernia repair, with removal and replacement
f mesh, possible resection of omentum and/or bowel, and possible
emoval of umbilical skin.
During the surgery, incarcerated omentum and prosthetic mesh
Fig. 1) partially within the hernia defect was revealed upon lysis of
ntra-abdominal adhesions. The omentum and mesh were reduced
ith some effort, amputated from the rest of the omentum, and
emoved. Instead of replacing the mesh with a new synthetic mesh,
 biologic graft was chosen due to the complexity of surgery and
ncreased risk for wound complications. Prior to implantation of
ew mesh, the hernia defect was closed primarily with inter-
upted sutures intra-corporeally and secured with titanium crimps.
hen the matrix was prepared by placing sutures extra-corporeally
nd then deployed through the 12 mm port site. Once carefully
dvanced into the abdomen, the matrix was ﬁxated with trans-
ascial sutures utilizing a suture passer device (Fig. 2). Titanium
piral tacks were used to further secure the matrix, with care being
aken to apply manual apposition of the abdominal wall against
he tacker. The matrix was  placed under physiologic tension with
he abdomen desufﬂated to minimum effective pressure (usually
–10 mm Hg). The 12 mm  port site was closed to prevent future
ncisional hernia. Additionally, intraoperative vascular imaging was
ig. 2. Under “physiologic tension” with abdomen, the matrix was  placed intraperi-
oneally, leaving at least 5 cm overlap around the defect. Matrix was  ﬁxated with
utures and secured with titanium spiral tacks.Fig. 3. The umbilical hernia was repaired with minimal wound proﬁle, through
which biologic mesh was inserted and also allowing preservation of suspected
ischemic skin.
performed on the thin, patchy areas of ecchymoses that were clin-
ically concerning for early ischemic changes on the umbilical skin.
Because adequate blood was  present, resection of compromised
skin was  not deemed necessary.
The patient was discharged home the same day of surgery and
was followed-up at postoperative week 1 and week 6 in ofﬁce. He
was free of wound complications except for a small, asymptomatic
seroma. He has had no evidence of recurrence, infection, or chronic
pain at nine months postoperative.
3. Discussion
In a patient with an incarcerated hernia with surrounding
ischemic skin and multiple comorbidities, retention of a minimally
invasive approach is important to minimize the risk of wound com-
plications and maintain the smallest wound proﬁle4,6 (Fig. 3). In
addition, implantation of a biologic matrix is advised to reduce
the incidence of mesh infection in patients at increased risk for
a negative recognition response to synthetic mesh. Biologic grafts
allow conservative management of possible infections and reduces
the need for downstream surgical interventions, such as explan-
tation of infected prosthesis.1,7 Additionally, utilization of biologic
matrix requires tissue apposition, which subsequently promotes
tissue regeneration and strengthening.
However, laparoscopic placement of biologic mesh can be
challenging. Biologic grafts can be too ﬁrm, which increases dif-
ﬁculty of handling, or too pliable, which can compromise its
integrity. StratticeTM Tissue Matrix Laparoscopic (LifeCell Corpora-
tion, Branchburg, NJ) was  the graft chosen for this patient’s repair.
Strattice Laparoscopic is a porcine dermal matrix manufactured
for laparoscopic use and was  recently FDA cleared. To the best
of our knowledge, this is the ﬁrst report discussing the use of
Strattice Laparoscopic. Compared to other biologic mesh, Strattice
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aparoscopic is thinner and more pliable but remains durable while
andling with laparoscopic instruments.
Defect closure essential in order to restore dynamic functional-
ty to the abdominal wall. Fewer incidences of recurrence have been
eported with reinforced defect closures compared to bridged mesh
epairs.8 Techniques for defect closure include percutaneous clo-
ure with a transfascial suture passer, intra-corporeal closure with
ree suturing, and device-assisted knot-tying. Given the patient’s
istory of hernia recurrence, the defect was closed in addition to
mplantation of mesh to reduce the risk of additional recurrences.
or the duration of the patient’s follow up, no recurrence or infec-
ion occurred. More importantly, the patient’s complex hernia case
id not result in further reoperations. Although its long term use
as yet to be determined in larger studies, this report suggests
atisfactory short term results.
. Conclusion
Incarcerated hernias are generally repaired with urgency and
aution. When further complicated with comorbidities and pre-
ious hernia repairs, the risk for infection is increased and the
echnique for repair becomes more signiﬁcant. In our case, a
aparoscopic approach with primary closure and reinforcement
with porcine dermal matrix was  safe and feasible for repair of an
incarcerated, recurrent hernia in a patient at high-risk for compli-
cations. Clinical studies with variable control should be conducted
to explore the full utility and effectiveness of this technique in
complex hernias.
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Key learning points
• Laparoscopic hernia repair with primary closure and reinforcement with laparoscopic biologic tissue was  achievable
for an incarcerated, recurrent umbilical hernia.
• Laser guided ﬂuorescent imaging may  be useful for assessing compromised umbilical skin during laparoscopic repair.
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